Donor-transmitted adenovirus infection causing kidney allograft nephritis and graft loss

被引:20
作者
Kozlowski, T. [1 ]
Nickeleit, V. [2 ]
Andreoni, K. [1 ,3 ]
机构
[1] Univ N Carolina, Dept Surg, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pathol, Chapel Hill, NC 27599 USA
[3] Ohio State Univ, Dept Surg, Columbus, OH 43210 USA
关键词
adenovirus; kidney transplant; transmitted infection; immunosuppression; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; OF-THE-LITERATURE; PEDIATRIC LIVER; VIRAL GENOME; RECIPIENTS; PCR; THERAPY; SERUM; THYMOGLOBULIN;
D O I
10.1111/j.1399-3062.2010.00572.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>Adenovirus (AdV) infection can occur early after transplantation, especially with potent immunosuppression for induction or acute rejection treatment. We present the largest case series of adult renal recipients from a single institution with AdV infection, and the first apparent case of transferred AdV infection from 1 deceased donor to 2 kidney recipients. Three patients received kidneys from 2 deceased donors: 2 from a 23-year-old donor, and the third from a 4-year-old donor. The recipients with the same donor both displayed early rejection. One who eventually lost his graft to AdV nephritis required treatment with plasmapheresis, intravenous immunoglobulin, rituximab, and anti-thymocyte globulin for severe antibody-mediated rejection. The second required only steroids for acute cellular rejection and has good renal function at 7 years. The third recipient was discovered to have AdV and microabscesess on renal biopsy and required nephrectomy. In the 2 cases of graft loss, we observed sudden deterioration of graft function with rising creatinine and subsequent necrosis resulting in nephrectomy within 40 days after transplantation. AdV was detected by polymerase chain reaction in urine or serum and/or renal tissue. AdV activation after potent immunosuppression can lead to systemic infection and may trigger rejection and/or early graft loss.
引用
收藏
页码:168 / 173
页数:6
相关论文
共 23 条
[1]   Short course induction immunosuppression with thymoglobulin for renal transplant recipients [J].
Agha, IA ;
Rueda, J ;
Alvarez, A ;
Singer, GG ;
Miller, BW ;
Flavin, K ;
Lowell, JA ;
Shenoy, S ;
Howard, TK ;
Ramachandran, V ;
Irish, W ;
Schnitzle, MA ;
Brennan, DC .
TRANSPLANTATION, 2002, 73 (03) :473-475
[2]   Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient [J].
Arav-Boger, R ;
Echavarria, M ;
Forman, M ;
Charache, P ;
Persaud, D .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (11) :1097-1100
[3]   Outcome and clinical course of 100 patients with adenovirus infection following bone marrow transplantation [J].
Baldwin, A ;
Kingman, H ;
Darville, M ;
Foot, ABM ;
Grier, D ;
Cornish, JM ;
Goulden, N ;
Oakhill, A ;
Pamphilon, DH ;
Steward, CG ;
Marks, DI .
BONE MARROW TRANSPLANTATION, 2000, 26 (12) :1333-1338
[4]   Intravenous cidofovir therapy for disseminated adenovirus in a pediatric liver transplant recipient [J].
Carter, BA ;
Karpen, SJ ;
Quiros-Tejeira, RE ;
Chang, IF ;
Clark, BS ;
Demmler, GJ ;
Heslop, HE ;
Scott, JD ;
Seu, P ;
Goss, JA .
TRANSPLANTATION, 2002, 74 (07) :1050-1052
[5]   Alemtuzumab (Campath-1H) in kidney transplantation [J].
Ciancio, G. ;
Burke, G. W., III .
AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (01) :15-20
[6]   PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals [J].
Echavarria, M ;
Forman, M ;
Ticehurst, J ;
Dumler, JS ;
Charache, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (11) :3323-3326
[7]   Prediction of severe disseminated adenovirus infection by serum PCR [J].
Echavarria, M ;
Forman, M ;
van Tol, MJD ;
Vossen, JM ;
Charache, P ;
Kroes, ACM .
LANCET, 2001, 358 (9279) :384-385
[8]   Adenovirus in kidney transplantation: An emerging pathogen? [J].
Emovon, OE ;
Rogers, J ;
Chavin, K ;
Self, S .
TRANSPLANTATION, 2004, 77 (09) :1474-1475
[9]   Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin [J].
Emovon, OE ;
Lin, A ;
Howell, DN ;
Afzal, F ;
Baillie, M ;
Rogers, J ;
Baliga, PK ;
Chavin, K ;
Nickeleit, V ;
Rajagapalan, PR ;
Self, S .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (11) :2436-2438
[10]   Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogeneic bone marrow transplantation [J].
Hatakeyama, N ;
Suzuki, N ;
Kudoh, T ;
Hori, T ;
Mizue, N ;
Tsutsumi, H .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2003, 22 (10) :928-929